SATIPHARM

Welcome to the Brand page for “SATIPHARM”, which is offered here for Custom manufacture and production of pharmaceutical and medicinal preparations and substances; purification and processing of cannabis and its cannabinoid constituents; custom manufacture and production of medicinal cannabis and medicinal products containing cannabinoids; drying of medicinal cannabis; milling of medicinal cannabis;biological tissue cultures for medical purposes; cannabis extracts for medical purposes; cannabis for medical purposes; cannabis oil for medical purposes; cannabis powder for medical purposes; cannabis resin for medical purposes; chemical preparations for medicinal purposes; drugs for medical purposes; drugs to be administered by inhalation; extracts of medicinal plants; extracts of plants in capsule form (for pharmaceutical use); herbal extracts for medicinal purposes; inhalation preparations for medical use; medicinal cannabis; medicinal cannabis derivatives; medicinal cannabis in capsule form; medicinal capsules; medicines for human use; medicinal cannabis products; medicinal ointments; medicinal preparations; medicinal tablets; oils for use in medicine; pharmaceutical compositions; pharmaceutical drugs; pharmaceutical preparations; plant extracts for medical use; plant extracts for pharmaceutical use; preparations for medicinal purposes derived from plants; preparations for medicinal purposes derived from flowers; topical cannabidiol (cbd) oils for medical use; topical preparations for medical use;agricultural advisory services; advisory services relating to pharmaceutical products; advisory services relating to the cultivation and production of cannabis; health and medical advisory services relating to the use of medicinal cannabis for the treatment of various medical conditions; horticultural services; cultivation and breeding of plants and cannabis for medical purposes; provision of information relating to medicinal cannabis; pharmacy dispensary services for medicinal cannabis; provision of pharmaceutical information; provision of information relating to medicine; provision of information to healthcare professionals relating to clinical trials involving medicinal cannabis;cannabis plant seeds; cannabis, unprocessed; dried flowers; live cannabis plants; natural plants and flowers; seeds for planting; tissue cultures being live plant material;agricultural research services; clinical trials; conducting clinical trials; medical research (scientific research for medical purposes); research relating to horticulture; research relating to plant breeding; scientific research relating to plant genetics; services for assessing the efficiency of drugs; pharmaceutical research services; research relating to medicine; research and development in the field of medicinal cannabis; research relating to pharmaceutical products; scientific and technological design relating to medicinal cannabis;.

Its status is currently believed to be active. Its class is unavailable. “SATIPHARM” is believed to be currently owned by “Cann Group Limited”.